Archive - January 2020
AbbVie lauds head-to-head win for Skyrizi versus Cosentyx
UK cell and gene clinical trials up 45% from 2018
Nektar’s opioid analgesic slammed with FDA panel rejection
Congenica launches new application Congenica Neuro
Lilly extends range of cut-price insulins in the US
NICE rejects Keytruda, asks for more info
Could gut bacteria guard against Parkinson’s?
NICE recommends Ibrance and Lynparza, rejects Keytruda and Xospata